Mumbai: Emcutix Biopharmaceuticals Ltd., a subsidiary of Emcure Pharmaceuticals, has announced the launch of SOLGLO – its new line of clinical-grade sunscreens featuring advanced formulations for superior UV and pollution protection.
The newly introduced products, SOLGLO Hybrid Sunscreen SPF 70 PA++++ and SOLGLO Invisible Sunscreen Gel SPF 50+ PA++++, are tailored to meet the growing needs of modern, skin-conscious consumers.
As urban living increasingly exposes skin to harsh environmental aggressors – ranging from harmful UVA/UVB rays to pollution and blue light – Emcutix Biopharmaceuticals’ SOLGLO range brings together high-efficacy sun protection and skin nourishment.
Designed as broad-spectrum sunscreens, both variants are dermatologist-tested on Indian skin types and suited for daily use across all climate zones.
“Sun care is no longer a cosmetic afterthought,” said Amal Kumar, Vice President, Marketing at Emcutix Biopharmaceuticals. “SOLGLO is crafted for the urban Indian who views SPF as essential to skin health. Each variant is designed with therapeutic precision to serve distinct dermatological needs.”
Two Variants, One Vision: Skin-First Sun Protection
SOLGLO Hybrid Sunscreen SPF 70 PA++++: A unique combination of physical and chemical UV filters delivers high-performance protection with an ultra-matte finish, making it ideal for sensitive and acne-prone skin.
SOLGLO Invisible Sunscreen Gel SPF 50+ PA++++: A shine-free, non-comedogenic formula that controls oil, moisturizes, and acts as a makeup primer, suitable for daily wear.
Both products are powered by Renouvellance (red algae), which acts as a natural anti-pollution agent, offering exposomal protection from urban stressors. Their lightweight texture, fast absorption, and non-greasy feel provide a cosmetically elegant user experience.
Emcutix Biopharmaceuticals: Redefining Sunscreen with Science
As part of its commitment to science-led skincare, Emcutix Biopharmaceuticals is redefining the Indian sunscreen landscape by introducing prescription-grade solutions that address both dermatological therapy and cosmetic needs. The Indian market for sun protection is witnessing strong growth, driven by awareness, digital influence, and increasing demand for pharma-backed personal care.
SOLGLO is now available via dermatologists, pharmacies, and leading e-commerce platforms.
